“Fentanyl is up to 50 times more powerful than heroin”
“From 1999 to 2016, opioid-related mortality rates – driven by synthetics – rapidly increased across the eastern United States, according to researchers at Stanford University. In 28 states, the mortality rates from synthetic opioids more than doubled every two years”.
At the present time, treatment for addicts is going through an enormous strain as specialists and clinicians search for innovative strategies to deal with a broad spectrum of addiction disorders, and battle America’s opioid pandemic. To that end, the National Conference on Addiction Disorders (NCAD), which has been running very successfully for the last decade, has just announced that it will now be having two annual conferences: the East and West.
These meetings are designed to empower professionals with clinically relevant, practical education to help treat addicts, and improve outcomes.Director of the Psychiatry & Behavioral Health Learning Network, (a HMP network which produces NCAD), Doug Edwards, stated that: “By expanding NCAD into two meetings we are now providing even more opportunities for professionals to gain the latest research that they can put immediately into practice”.
NCAD East will be held in Baltimore, MD, on August 15-18, 2019.
NCAD West will be held in Denver, CO, on October 24-26, 2019.
And although the goal of both sessions is to deal with addiction disorders, each conference will have its own unique focus. The talks will be conducted by key leaders in the field and will impart vital education on various addictive disorders. Further, it will put the spotlight on the latest research on fresh treatment initiatives.
This offers an all-encompassing clinical agenda which comprises a series of very interesting and specific tracks. The latter are delivered in conjunction with the Behavioral Health Association Providers (BHAP). Over 1,000 professional participants are expected to attend to learn about cutting-edge research. They will also have the opportunity to: “share cross-discipline insight on forward-thinking topics such as medication-assisted treatment, benzodiazepine use, utilization of genetic information in treatment, and advances in treatment technologies”
This clinical schedule will center on the junction of medication assisted, and traditional treatment programs. Providers of these two options, along with a 12-Step treatment protocol, will unite for a robust thought and education exchange focused on generating a recovery driven, patient focused care system.
More About HMP
HMP is the powerhouse supporting Healthcare Made Practical. – It is renowned as a multi-channel leader in educational and health care conferences, with a goal to ameliorate the care of patients. The organization delivers top level clinically-relevant, medical educational events, which have received prior accreditation; as well as evidence-based content over several therapeutic areas, for the world-wide health care community.
HMP’s brands incorporate among others: the biggest independent mental health conference in America: Psych Congress; and the Rx Drug Abuse & Heroin Summit – the country’s premier meeting centered on addressing the opioid abuse epidemic.